Login / Signup
Weighing the Cardiovascular Risks of Low-Dose Glucocorticoids in Rheumatoid Arthritis from Real-World Data.
Tate M Johnson
Published in:
Arthritis & rheumatology (Hoboken, N.J.) (2024)
Keyphrases
</>
low dose
rheumatoid arthritis
electronic health record
high dose
disease activity
big data
human health
ankylosing spondylitis
interstitial lung disease
systemic lupus erythematosus
artificial intelligence
climate change
deep learning
idiopathic pulmonary fibrosis